Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voriconazole in Invasive Fungal Infection
NCT00647907Phase 4Completed
- Sponsor
- Pfizer
- Start
- Apr 2003
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of voriconazole in candidiasis, cryptococcosis, aspergillosis, sponsored by Pfizer. Started Apr 2003; status: completed.
02
Drugs
voriconazole
03
Conditions
candidiasiscryptococcosisaspergillosis
Beyond the preview
Go deeper on NCT00647907.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00647907.